Drug Profile
AL 43546
Alternative Names: AL-43,546Latest Information Update: 15 Apr 2019
Price :
$50
*
At a glance
- Originator Alcon
- Class Mannans
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Dry eyes
Most Recent Events
- 09 Apr 2019 Novartis completed the spin-off of Alcon eye care devices business
- 29 Jul 2015 No recent reports on development identified - Phase-II for Dry eyes in USA (Ophthalmic)
- 29 Jul 2015 No recent reports on development identified - Phase-III for Dry eyes in Japan (Ophthalmic)